Who
Amit Kumar
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Anixa Biosciences; Director, Ascent Solar Technologies; Director, Aeolus Pharmaceuticals; President and CEO, CombiMatrix; Pres/CEO of CombiMatrix Corp., Acacia Research.
In numbers
- Trades disclosed
- 332
- Buys
- 102
- Sells
- 4
- Bought
- $1.9M
- Sold
- $492K
- Companies
- 5
- Companies where not an officer
- 2
- First trade
- 18 Jul 2006
- Last trade
- 22 Oct 2026
- Last filed
- 22 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Oct 2026filed 22 Oct 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $22K8,000 at $2.72 | filing |
| 24 Sep 2026filed 28 Sep 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $19K7,000 at $2.78 | filing |
| 24 Sep 2026filed 28 Sep 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $19K7,000 at $2.78 | filing |
| 10 Sep 2026filed 14 Sep 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $8,2503,000 at $2.75 | filing |
| 10 Sep 2026filed 14 Sep 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $8,2503,000 at $2.75 | filing |
| 10 Sep 2026filed 11 Sep 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $14K5,000 at $2.76 | filing |
| 10 Sep 2026filed 11 Sep 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $14K5,000 at $2.76 | filing |
| 31 Jul 2026filed 3 Aug 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $17K5,000 at $3.47 | filing |
| 31 Jul 2026filed 3 Aug 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $17K5,000 at $3.47 | filing |
| 27 Jul 2026filed 28 Jul 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $17K5,000 at $3.44 | filing |
| 27 Jul 2026filed 28 Jul 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $17K5,000 at $3.44 | filing |
| 27 Jul 2026filed 27 Jul 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $11K3,188 at $3.37 | filing |
| 27 Jul 2026filed 27 Jul 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $11K3,188 at $3.37 | filing |
| 24 Jul 2026filed 27 Jul 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $11K3,000 at $3.73 | filing |
| 24 Jul 2026filed 27 Jul 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $11K3,000 at $3.73 | filing |
| 20 Jul 2026filed 21 Jul 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $17K5,000 at $3.46 | filing |
| 20 Jul 2026filed 21 Jul 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $17K5,000 at $3.46 | filing |
| 10 Jul 2026filed 13 Jul 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $15K5,000 at $3.04 | filing |
| 10 Jul 2026filed 13 Jul 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $15K5,000 at $3.04 | filing |
| 12 Jun 2026filed 16 Jun 2026 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $53K21,000 at $2.50 | filing |
News
Anixa Biosciences (NASDAQ:ANIX) CEO Amit Kumar Purchases 8,000 Shares of Company Stockthemarketsdaily.com · 23 Oct 2026Anixa Biosciences (NASDAQ:ANIX) Stock: Insider Amit Kumar Purchases 8,000 Sharesdailypolitical.com · 22 Oct 2026Puspika Amit Kumar vs State Of Rajasthan on 13 October, 2026indiankanoon.org · 14 Oct 2026Google Cloud appoints Amit Kumar as interim MD, replacing Sashikumar Sreedharanmoneycontrol.com · 7 Oct 2026Amit Kumar Vishwakarma vs National Highways Authority Of India ... on 4 October, 2026indiankanoon.org · 6 Oct 2026Anixa Biosciences (NASDAQ:ANIX) Stock: Insider Amit Kumar Purchases 7,000 Sharesdailypolitical.com · 30 Sep 2026Amit Choubey @ Amit Kumar Choubey @ Ankit ... vs State Of Bihar And Anr on 22 September, 2026indiankanoon.org · 24 Sep 2026Amit Kumar Gupta Gets Addl Charge As Registrar At HC's Delhi Officedailyexcelsior.com · 19 Sep 2026Immatics (NASDAQ:IMTX) & Anixa Biosciences (NASDAQ:ANIX) Financial ComparisonANIX · dailypolitical.com · 16 Oct 2026Join Anixa Biosciences' Live Investor Webinar: Advancing Innovative CAR-T Therapy for Ovarian Cancer and a First-in-Class Breast Cancer VaccineANIX · hawaiitelegraph.com · 13 Oct 2026
10 headlines in the last 90 days name Amit Kumar; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.